Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency.

Literature DB >> 108708

Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency.

T Ljungberg, U Ungerstedt.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1979 PMID： 108708 DOI： 10.1007/bf00426672

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

× No keyword cloud information.

13 in total

1. Differential attenuation of some effects of haloperidol in rats given scopolamine.

Authors: P Setler; H Sarau; G McKenzie
Journal: Eur J Pharmacol Date: 1976-09 Impact factor: 4.432

2. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors: T Ljungberg; U Ungerstedt
Journal: Psychopharmacology (Berl) Date: 1978-04-11 Impact factor: 4.530

3. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors: I Creese; D R Burt; S H Snyder
Journal: Science Date: 1976-04-30 Impact factor: 47.728

Review 4. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

Authors: S Matthysse
Journal: Fed Proc Date: 1973-02

5. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.

Authors: B Costall; R J Naylor
Journal: Eur J Pharmacol Date: 1973-10 Impact factor: 4.432

6. Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.

Authors: S H Snyder; D Greenberg; H I Yamumura
Journal: J Psychiatr Res Date: 1974 Impact factor: 4.791

7. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.

Authors: R J Miller; C R Hiley
Journal: Nature Date: 1974-04-12 Impact factor: 49.962

8. Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal.

Authors: H R Bürki; E Eichenberger; A C Sayers; T G White
Journal: Pharmakopsychiatr Neuropsychopharmakol Date: 1975-05

9. The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine).

Authors: G Stille; H Lauener; E Eichenberger
Journal: Farmaco Prat Date: 1971-10

10. Different behavioural patterns induced by apomorphine: evidence that the method of administration determines the behavioural response to the drug.

Authors: T Ljungberg; U Ungerstedt
Journal: Eur J Pharmacol Date: 1977-11-01 Impact factor: 4.432

8 in total

1. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors: T Ljungberg; U Ungerstedt
Journal: Psychopharmacology (Berl) Date: 1978-04-11 Impact factor: 4.530

2. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.

Authors: J R Blackburn; A G Phillips
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

6. Acute and subchronic effects of clozapine on licking in rats: tolerance to disruptive effects on number of licks, but no tolerance to rhythm slowing.

Authors: S Das; S C Fowler
Journal: Psychopharmacology (Berl) Date: 1995-08 Impact factor: 4.530

7. Unlike haloperidol, clozapine slows and dampens rats' forelimb force oscillations and decreases force output in a press-while-licking behavioral task.

Authors: S C Fowler; K H Davison; J A Stanford
Journal: Psychopharmacology (Berl) Date: 1994-09 Impact factor: 4.530

8. Effects of fluperlapine on dopaminergic systems in rat brain.

Authors: H R Burki
Journal: Psychopharmacology (Berl) Date: 1986 Impact factor: 4.530